Suraksha Diagnostic Limited is a prominent diagnostic service provider in India, primarily serving the eastern region, especially West Bengal. Established in 1992, the company offers a comprehensive range of healthcare diagnostic services, including:
- Pathology Services: Blood tests, histopathology, microbiology, clinical biochemistry, and advanced molecular diagnostics like next-generation sequencing.
- Radiology Services: Imaging services such as MRI, CT scans, X-rays, ultrasounds, and mammography.
- Specialized Tests: Neurology tests like EEG and EMG, cardiology evaluations like ECG and stress tests, and gastroenterology procedures such as endoscopy and colonoscopy.
Network and Presence
Suraksha operates one central reference laboratory and eight satellite labs, alongside a network of over 215 customer touchpoints (collection centers) across West Bengal, Bihar, Assam, and Meghalaya. This extensive reach allows it to cater to both urban and semi-urban populations.
Market Position
As of FY24, the company conducted nearly 6 million diagnostic tests for about 1.1 million patients. West Bengal alone contributes over 95% of its revenue. With its focus on affordable and reliable healthcare services, it has captured around 1.15-1.3% of the diagnostics market in the eastern region.
Financial Performance
Suraksha’s revenue reached ₹219 crore in FY24, with a 34% operating profit margin. Despite facing competitive pressures and regional concentration, the company has shown steady growth in tests performed and revenue per patient.
Suraksha Diagnostic Limited IPO Timetable
| Particular | Date |
| IPO Open Date | 29 Nov 2024 |
| IPO Close Date | 03 Dec 2024 |
| Allotment Date | 04 Dec 2024 |
| IPO Listing Date | 06 Dec 2024 |
Suraksha Diagnostic Limited IPO Details
| Issue Type | Book Built Issue IPO |
| Face Value | Rs. 2 Per Equity Share |
| IPO Price | Rs. 420 to Rs. 441 Per Equity Share |
| Market Lot | 34 Share |
| ISIN Code | |
| Listing At | NSE & BSE |
| Issue Size | Approx. Rs. 846 Crore. |
Suraksha Diagnostic Limited IPO Lot Size
| Application | Lots | Shares | Amount |
| Minimum | 1 | 34 | Rs. 14994 |
| Maximum | 13 | 442 | Rs. 194922 |
| Small HNI (Minimum) | 14 | 476 | Rs. 209916 |
| Big HNI (Minimum) | 67 | 2278 | Rs. 1004598 |
Suraksha Diagnostic Limited IPO Allotment Status
Click Here To Check IPO Allotment Status Suraksha Diagnostic Limited IPO
Click Here To Get ASBA Forms Suraksha Diagnostic Limited IPO
Company Financials:
| Particular | 31 March 2024 | 31 March 2023 | 31 March 2022 |
| Total Assets | 300.21 | 281.20 | 275.96 |
| Total Revenue | 222.26 | 193.69 | 225.77 |
| Profit After Tax | 23.13 | 6.07 | 20.82 |
Company Promoters:
The promoters of the company are Dr. Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma.
Objects of this Issue:
- The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Registrar & Company Details
| Company Contact Information | IPO Registrar |
| Suraksha Diagnostic Limited Plot No. DG-12/1 Action Area 1D, Premises No. 02-0327 New Town, Rajarhat Kolkata 700 156 Phone: 91 33 66059750 Email: investors@surakshanet.com Website: https://www.surakshanet.com | Kfin Technologies Limited Phone: 04067162222, 04079611000 Email: sdl.ipo@kfintech.com Website: https://kosmic.kfintech.com/ipostatus/ |
